Clostridioides difficile Testing

Clostridioides difficile (C. difficile) testing refers to the diagnostic procedures used to detect the presence of C. difficile bacteria in a patient's stool sample. C. difficile is a type of bacteria that can cause diarrhea, colitis, and other gastrointestinal symptoms, particularly in individuals who have taken antibiotics.

Types of C. difficile Tests

  • Enzyme Immunoassay (EIA): This test detects the presence of toxins A and B produced by C. difficile in a stool sample. EIA is a rapid and relatively inexpensive test, but it may not be as sensitive as other methods.
  • Polymerase Chain Reaction (PCR): PCR is a molecular test that detects the genetic material of C. difficile in a stool sample. It is highly sensitive and specific, making it a popular choice for diagnosing C. difficile infections.
  • Stool Culture: This test involves culturing a stool sample to grow C. difficile bacteria. Stool culture is considered the gold standard for diagnosing C. difficile infection, but it can take several days to obtain results.
  • Toxin Detection by Cell Culture Neutralization Assay (CCNA): This test detects the presence of toxins A and B produced by C. difficile in a stool sample using cell culture techniques. CCNA is highly sensitive and specific, but it can be time-consuming and labor-intensive.

Indications for Testing

C. difficile testing is typically indicated in patients who present with the following symptoms:

Testing is particularly important for patients who have recently taken antibiotics, as they are at increased risk of developing C. difficile infection.

Specimen Collection and Handling

A stool sample is typically collected from the patient and sent to a laboratory for testing. The specimen should be handled and stored properly to ensure accurate test results:

  • The stool sample should be collected in a clean, dry container.
  • The specimen should be refrigerated at 2-8°C (36-46°F) within two hours of collection.
  • The specimen should be transported to the laboratory as soon as possible.

Test Results and Interpretation

The results of C. difficile testing can be interpreted as follows:

  • A positive test result indicates the presence of C. difficile bacteria or toxins in the stool sample, suggesting a diagnosis of C. difficile infection.
  • A negative test result suggests that C. difficile is not present in the stool sample, but it does not rule out other causes of diarrhea or gastrointestinal symptoms.

It is essential to consider the patient's clinical presentation and medical history when interpreting test results, as false-positive or false-negative results can occur.

Frequently Asked Questions (FAQs)

What is Clostridioides difficile testing?
Testing for the presence of C. difficile bacteria in stool samples.

Why is C. difficile testing performed?
To diagnose C. difficile infection (CDI) in patients with symptoms such as diarrhea, abdominal pain, and fever.

What are the common methods of C. difficile testing?
Stool tests, including enzyme immunoassay (EIA), polymerase chain reaction (PCR), and toxin detection assays.

How is a stool sample collected for C. difficile testing?
A stool sample is typically collected in a sterile container and sent to a laboratory for analysis.

What are the risks associated with C. difficile testing?
Generally considered low-risk, but may include minor discomfort during stool collection.

How long does it usually take to get results from C. difficile testing?
Results can vary, typically taking several hours to several days, depending on the test method and laboratory.

What do positive C. difficile test results indicate?
Presence of C. difficile bacteria or toxins in the stool sample, suggesting a possible infection.

Can C. difficile testing be performed on patients with inflammatory bowel disease (IBD)?
Yes, but results should be interpreted with caution, as IBD patients may have false-positive results.

Are there any medications that can affect C. difficile testing results?
Possibly, certain antibiotics and other medications may impact test accuracy or results.

Is C. difficile testing used to monitor treatment response?
Yes, repeat testing may be performed to assess treatment efficacy and detect potential recurrence of infection.

Article last updated on: 18th October 2025.
If you have any feedback, please get in touch.

See more

 Conditions  Symptoms  Procedures

Diagnosis Pad
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.
Download from App Store Download from Google Play
Available for iOS, macOS and Android.

Medical Disclaimer

The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. We we do not guarantee, and assume no legal liability or responsibility for the accuracy, currency, or completeness of the information provided.